Phenols
eMolecules 126-33-0 | Sulfolane | Oakwood Chemicals | MFCD00005484 | 120.170 | C4H8O2S | 99.000 | O=S1(=O)CCCC1 | 100g | 480131565
Sulfolane | Oakwood Chemicals | 126-33-0 | MFCD00005484 | 120.170 | C4H8O2S | 99.000 | O=S1(=O)CCCC1 | 100g | 480131565
eMolecules 693232-06-3 | 2-Bromo-3-hydroxybenzonitrile | Ambeed | MFCD09266204 | 198.019 | C7H4BrNO | 98.000 | Oc1cccc(C#N)c1Br | 1g | 490562838
2-Bromo-3-hydroxybenzonitrile | Ambeed | 693232-06-3 | MFCD09266204 | 198.019 | C7H4BrNO | 98.000 | Oc1cccc(C#N)c1Br | 1g | 490562838
![eMolecules 2055839-77-3 | 1-{3-hydroxybicyclo[1.1.1]pentan-1-yl}ethan-1-one | Pharmablock | MFCD30530452 | 126.155 | C7H10O2 | 97.000 | CC(=O)C12CC(O)(C1)C2 | 1g | 551183516](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000160557.jpg-250.jpg)
eMolecules 2055839-77-3 | 1-{3-hydroxybicyclo[1.1.1]pentan-1-yl}ethan-1-one | Pharmablock | MFCD30530452 | 126.155 | C7H10O2 | 97.000 | CC(=O)C12CC(O)(C1)C2 | 1g | 551183516
1-{3-hydroxybicyclo[1.1.1]pentan-1-yl}ethan-1-one | Pharmablock | 2055839-77-3 | MFCD30530452 | 126.155 | C7H10O2 | 97.000 | CC(=O)C12CC(O)(C1)C2 | 1g | 551183516
Apexbio Technology LLC LX-1031 945976-76-1 10mM (in 1mL DMSO)
LX-1031 (CAS 945976-76-1) is an orally administered small-molecule inhibitor of tryptophan hydroxylase (TPH) the rate-limiting enzyme in peripheral serotonin (5-HT) biosynthesis As a heterocyclic phenylalanine analogue LX-1031 selectively reduces 5-HT synthesis outside the central nervous system In vitro LX-1031 suppresses TPH1 activity within nanomolar concentration ranges In animal studies oral administration leads to dose-dependent reductions in jejunal 5-HT levels Clinical investigations have demonstrated that LX-1031 lowers urinary 5-hydroxyindoleacetic acid (5-HIAA) reflecting decreased peripheral serotonin turnover LX-1031 is under investigation for disorders characterized by elevated peripheral 5-HT such as diarrhea-predominant irritable bowel syndrome
Cambridge Isotope Laboratories Bisphenol F (unlabeled) 100 ug/mL in acetonitrile 1 2 mL
Bisphenol F (unlabeled) 100 ug/mL in acetonitrile 1 2 mL
Cambridge Isotope Laboratories 3 4-DiBDE (BDE-12) (unlabeled) 50 ug/mL in nonane 1 2 mL
3 4-DiBDE (BDE-12) (unlabeled) 50 ug/mL in nonane 1 2 mL
Cambridge Isotope Laboratories 2-Isopropyl-5-methylphenol (isopropyl-13C3 99%) 100 ug/mL in methanol 1 2 mL
2-Isopropyl-5-methylphenol (isopropyl-13C3 99%) 100 ug/mL in methanol 1 2 mL
Cambridge Isotope Laboratories 5-Isopropyl-2-methylphenol (isopropyl-13C3 99%) 1 mg/mL in methanol 1 2 mL
5-Isopropyl-2-methylphenol (isopropyl-13C3 99%) 1 mg/mL in methanol 1 2 mL
Cambridge Isotope Laboratories 4-Chloro-3-methylphenol (ring-2 6-D2 98%) 0 01 g
4-Chloro-3-methylphenol (ring-2 6-D2 98%) 0 01 g
Medchemexpress LLC Rho-Kinase-IN-2 | 2573071-18-6 | C20H25FN4O2 | 100 MG
Rho-Kinase-IN-2 (Compound 23) is an orally active, selective, and CNS-penetrant Rho Kinase (ROCK) inhibitor with a ROCK2 IC50 of 3 nM, making it suitable for Huntington's research. It increases AKT phosphorylation and decreases MYPT1 phosphorylation both in vitro and in vivo. This product is intended for research use only.
- Orally active, selective, and CNS-penetrant ROCK inhibitor
- Targeted inhibition of ROCK2 with an IC50 of 3 nM
- Increases AKT phosphorylation and decreases MYPT1 phosphorylation in A7r5 and PANC1 cells
- Demonstrates dose- and time-dependent ROCK1 and ROCK2 target engagement in vivo
- Shows excellent tolerability in mouse models
- Decreases mean arterial, systolic, and diastolic blood pressure and heart rate in CD1 mice